KalVista Pharmaceuticals ... (KALV)
NASDAQ: KALV
· Real-Time Price · USD
12.89
-0.06 (-0.46%)
At close: Aug 15, 2025, 3:59 PM
13.13
1.82%
After-hours: Aug 15, 2025, 07:39 PM EDT
KalVista Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
May - April.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 |
Cash & Equivalents | 98.64M | 167.29M | 41.58M | 31.85M | 31.79M | 23.06M | 57.67M | 49.41M | 56.24M | 85.05M | 38.59M | 37.86M | 30.73M | 45.58M | 46.49M | 48.34M | 50.59M | 17.73M | 16.17M | 18.01M |
Short-Term Investments | 89M | 85.92M | 94.19M | 142.42M | 178.61M | 52.53M | 45.51M | 73.85M | 93.14M | 86.64M | 83.69M | 104.21M | 135.47M | 149.21M | 163.32M | 182.29M | 198.34M | 32.58M | 39.7M | 46.32M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 7.09M | 1.39M | 662K | 605K | 567K | 397K | 337K | 106K | 106K | 197K | 197K | 218K | 193K | 193K | 193K | 200K | 200K | 181K | 178K | 178K |
Receivables | n/a | 9.4M | n/a | 12.29M | 10.87M | 23.68M | 21.3M | 20.57M | 16.57M | n/a | 21.93M | n/a | n/a | 11.29M | 17.4M | 13.61M | 10.42M | 7.59M | 14.69M | 12.64M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | -21.3M | -20.57M | n/a | n/a | n/a | n/a | 2.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 34.35M | n/a | 16.49M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 241.69M | 267.36M | 152.27M | 191.63M | 225.69M | 104.1M | 128.61M | 149.84M | 172.33M | 192.13M | 151.22M | 170.41M | 193.65M | 214.46M | 234.48M | 249.78M | 264.26M | 62.5M | 72.08M | 80.22M |
Property-Plant & Equipment | 1.99M | 7.25M | 7.9M | 7.96M | 9.15M | 9.47M | 9.8M | 10.38M | 10.77M | 11.14M | 11.43M | 11.69M | 10.04M | 10.39M | 9.14M | 9.15M | 7.55M | 3.52M | 3.19M | 3.5M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 9.08M | 8.63M | 8.56M | 8.56M | 9.71M | 9.87M | 10.14M | 10.49M | 10.88M | 11.34M | 11.62M | 11.91M | 10.23M | 10.59M | 9.33M | 9.35M | 7.75M | 3.7M | 3.37M | 3.68M |
Total Assets | 250.77M | 275.99M | 160.83M | 200.2M | 235.4M | 113.97M | 138.74M | 160.33M | 183.2M | 203.47M | 162.84M | 182.32M | 203.88M | 225.05M | 243.81M | 259.13M | 272.01M | 66.21M | 75.45M | 83.9M |
Account Payables | 4.88M | 5.86M | 5.2M | 10.79M | 9.11M | 3.1M | 4.9M | 5.06M | 4.82M | 1.7M | 3.38M | 2.91M | 3.64M | 2.19M | 3.16M | 1.45M | 1.98M | 641K | 2.17M | 1.77M |
Deferred Revenue | 11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -997K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | 1.26M | n/a | 1.19M | 1.15M | 1.12M | 1.09M | 1.06M | 1.03M | 997K | 977K | 1.01M | 930K | 905K | n/a | 592K | 422K | 513K |
Other Current Liabilities | n/a | 9.55M | 6.98M | 5.93M | n/a | 8.19M | 6.71M | 4.33M | 3.83M | 3.68M | 2.79M | 2.77M | 3.19M | 2.24M | 2.69M | 3.39M | n/a | 2.46M | 3.57M | 2.71M |
Total Current Liabilities | 45.17M | 25.61M | 22.16M | 22.41M | 22.81M | 19.13M | 17.75M | 14.13M | 15.03M | 11.61M | 11.32M | 9.73M | 11.58M | 9.65M | 10.11M | 8.23M | 9.77M | 6.52M | 9.54M | 8.46M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | 100.91M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 110.21M | 105.25M | 4.67M | 4.99M | 6.01M | 6.26M | 6.55M | 6.87M | 7.14M | 7.42M | 7.71M | 8.01M | 7.21M | 7.47M | 6.22M | 6.47M | 5.05M | 1.12M | 932K | 1.01M |
Total Liabilities | 155.38M | 130.87M | 26.84M | 27.4M | 28.82M | 25.39M | 24.3M | 21M | 22.18M | 19.03M | 19.02M | 17.75M | 18.79M | 17.12M | 16.34M | 14.7M | 14.82M | 7.64M | 10.47M | 9.47M |
Total Debt | 6.31M | 5.78M | 6.21M | 6.25M | 7.32M | 7.44M | 7.69M | 7.99M | 8.23M | 8.48M | 8.73M | 9.01M | 8.19M | 8.48M | 7.15M | 7.38M | 5.91M | 1.72M | 1.35M | 1.52M |
Common Stock | 50K | n/a | n/a | 43K | 42K | 34K | 34K | 34K | 34K | 34K | 25K | 25K | 25K | 24K | 24K | 24K | 24K | 18K | 18K | 18K |
Retained Earnings | -653.17M | -600.95M | -552.44M | -510.17M | -469.73M | -425.08M | -396.05M | -368.4M | -343.08M | -316.78M | -295.47M | -273.22M | -250.18M | -226.06M | -203.59M | -183.94M | -167.84M | -152.88M | -142.83M | -132.41M |
Comprehensive Income | -5.21M | -2.21M | -2.7M | -2.87M | -3.49M | -3.29M | -3.46M | -2.89M | -3.06M | -3.54M | -5.33M | -4.15M | -3.86M | -2.34M | -1.72M | -1.49M | -1.43M | -1.27M | -1.96M | -1.62M |
Shareholders Equity | 95.39M | 145.13M | 133.99M | 172.8M | 206.58M | 88.58M | 114.45M | 139.34M | 161.03M | 184.44M | 143.81M | 164.57M | 185.09M | 207.94M | 227.47M | 244.43M | 257.19M | 58.56M | 64.98M | 74.44M |
Total Investments | 89M | 85.92M | 94.19M | 142.42M | 178.61M | 52.53M | 45.51M | 73.85M | 93.14M | 86.64M | 83.69M | 104.21M | 135.47M | 149.21M | 163.32M | 182.29M | 198.34M | 32.58M | 39.7M | 46.32M |